Concepts (378)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 42 | 2025 | 1072 | 12.650 |
Why?
|
| Apolipoprotein E4 | 17 | 2025 | 267 | 6.790 |
Why?
|
| Alzheimer Disease | 23 | 2025 | 2148 | 4.980 |
Why?
|
| Aged | 82 | 2025 | 9339 | 3.570 |
Why?
|
| Cognition | 30 | 2024 | 1371 | 3.360 |
Why?
|
| tau Proteins | 6 | 2025 | 239 | 2.960 |
Why?
|
| Chicago | 29 | 2025 | 941 | 2.890 |
Why?
|
| Neurofilament Proteins | 4 | 2025 | 17 | 2.840 |
Why?
|
| Female | 88 | 2025 | 15793 | 2.750 |
Why?
|
| Male | 78 | 2025 | 15367 | 2.630 |
Why?
|
| Cognition Disorders | 14 | 2018 | 1020 | 2.610 |
Why?
|
| Stroke | 6 | 2023 | 278 | 2.520 |
Why?
|
| Humans | 105 | 2025 | 28462 | 2.430 |
Why?
|
| Neurodegenerative Diseases | 3 | 2025 | 124 | 2.430 |
Why?
|
| Aged, 80 and over | 41 | 2025 | 4904 | 2.410 |
Why?
|
| Longitudinal Studies | 28 | 2025 | 1391 | 2.360 |
Why?
|
| Aging | 14 | 2025 | 1572 | 2.180 |
Why?
|
| Cohort Studies | 25 | 2025 | 1948 | 2.100 |
Why?
|
| Biomarkers | 11 | 2025 | 601 | 2.060 |
Why?
|
| Risk Factors | 25 | 2025 | 2421 | 1.920 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2025 | 42 | 1.880 |
Why?
|
| Apolipoproteins E | 8 | 2023 | 254 | 1.850 |
Why?
|
| Alleles | 9 | 2024 | 213 | 1.830 |
Why?
|
| Blood Pressure | 3 | 2024 | 204 | 1.590 |
Why?
|
| Exercise | 9 | 2023 | 476 | 1.540 |
Why?
|
| White Matter | 3 | 2022 | 142 | 1.530 |
Why?
|
| Activities of Daily Living | 9 | 2018 | 612 | 1.520 |
Why?
|
| Population Surveillance | 3 | 2021 | 110 | 1.420 |
Why?
|
| Prospective Studies | 15 | 2025 | 1810 | 1.390 |
Why?
|
| Dementia | 9 | 2024 | 580 | 1.300 |
Why?
|
| Vitamin E | 2 | 2023 | 45 | 1.260 |
Why?
|
| Intermediate Filaments | 4 | 2023 | 20 | 1.250 |
Why?
|
| Genotype | 7 | 2024 | 352 | 1.190 |
Why?
|
| Incidence | 12 | 2025 | 779 | 1.170 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 373 | 1.150 |
Why?
|
| Memory Disorders | 3 | 2024 | 171 | 1.120 |
Why?
|
| Disease Progression | 11 | 2019 | 719 | 1.110 |
Why?
|
| Dietary Approaches To Stop Hypertension | 2 | 2024 | 37 | 1.100 |
Why?
|
| Loneliness | 2 | 2025 | 63 | 1.090 |
Why?
|
| Diet, Mediterranean | 3 | 2024 | 101 | 1.050 |
Why?
|
| Mortality | 4 | 2021 | 88 | 1.040 |
Why?
|
| Lipids | 1 | 2025 | 51 | 0.940 |
Why?
|
| Social Isolation | 1 | 2025 | 30 | 0.940 |
Why?
|
| Dietary Fats | 1 | 2024 | 39 | 0.890 |
Why?
|
| United States | 12 | 2024 | 2185 | 0.890 |
Why?
|
| Disability Evaluation | 4 | 2014 | 293 | 0.890 |
Why?
|
| Whole Grains | 1 | 2023 | 7 | 0.880 |
Why?
|
| Neuropathology | 3 | 2021 | 85 | 0.830 |
Why?
|
| Depression | 4 | 2014 | 454 | 0.800 |
Why?
|
| Vitamin D | 1 | 2022 | 41 | 0.780 |
Why?
|
| Healthy Lifestyle | 5 | 2024 | 46 | 0.780 |
Why?
|
| Antihypertensive Agents | 2 | 2021 | 71 | 0.750 |
Why?
|
| Independent Living | 5 | 2025 | 320 | 0.740 |
Why?
|
| Membrane Proteins | 1 | 2021 | 174 | 0.690 |
Why?
|
| Geriatric Assessment | 5 | 2021 | 214 | 0.660 |
Why?
|
| Follow-Up Studies | 11 | 2024 | 1868 | 0.620 |
Why?
|
| Neuropsychological Tests | 11 | 2018 | 1254 | 0.600 |
Why?
|
| Time Factors | 10 | 2021 | 1497 | 0.580 |
Why?
|
| Diet | 4 | 2023 | 221 | 0.580 |
Why?
|
| Art | 1 | 2016 | 1 | 0.550 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 382 | 0.540 |
Why?
|
| Mental Status and Dementia Tests | 3 | 2023 | 69 | 0.530 |
Why?
|
| Music | 1 | 2016 | 23 | 0.530 |
Why?
|
| Diabetes Complications | 1 | 2016 | 59 | 0.530 |
Why?
|
| Models, Statistical | 2 | 2021 | 128 | 0.520 |
Why?
|
| Life Style | 5 | 2022 | 198 | 0.510 |
Why?
|
| Prevalence | 3 | 2023 | 473 | 0.490 |
Why?
|
| Obesity | 6 | 2014 | 322 | 0.490 |
Why?
|
| Mobility Limitation | 2 | 2015 | 95 | 0.480 |
Why?
|
| Cognitive Aging | 4 | 2021 | 79 | 0.480 |
Why?
|
| Body Mass Index | 6 | 2018 | 466 | 0.460 |
Why?
|
| Depressive Disorder | 1 | 2015 | 184 | 0.460 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 18 | 0.450 |
Why?
|
| Memantine | 1 | 2014 | 9 | 0.450 |
Why?
|
| Dopamine Agents | 1 | 2014 | 16 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 191 | 0.440 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2021 | 285 | 0.440 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 291 | 0.440 |
Why?
|
| Antioxidants | 1 | 2014 | 65 | 0.430 |
Why?
|
| Motor Activity | 2 | 2015 | 331 | 0.420 |
Why?
|
| Health Status Disparities | 1 | 2013 | 75 | 0.410 |
Why?
|
| Memory, Episodic | 3 | 2018 | 116 | 0.400 |
Why?
|
| Diagnosis | 1 | 2011 | 24 | 0.390 |
Why?
|
| Area Under Curve | 1 | 2011 | 63 | 0.380 |
Why?
|
| Medical Informatics | 1 | 2011 | 10 | 0.380 |
Why?
|
| Linear Models | 3 | 2016 | 255 | 0.360 |
Why?
|
| Refusal to Participate | 1 | 2010 | 2 | 0.360 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 494 | 0.350 |
Why?
|
| Disabled Persons | 1 | 2012 | 125 | 0.350 |
Why?
|
| Age of Onset | 3 | 2014 | 99 | 0.310 |
Why?
|
| Genetic Loci | 3 | 2018 | 54 | 0.300 |
Why?
|
| Middle Aged | 21 | 2019 | 9306 | 0.300 |
Why?
|
| Postmenopause | 7 | 2006 | 57 | 0.280 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 1196 | 0.260 |
Why?
|
| Triglycerides | 2 | 2025 | 62 | 0.250 |
Why?
|
| Neuroticism | 2 | 2023 | 32 | 0.250 |
Why?
|
| Hypertension | 2 | 2024 | 226 | 0.240 |
Why?
|
| Hypoglycemic Agents | 2 | 2016 | 40 | 0.240 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.240 |
Why?
|
| Air Pollutants | 1 | 2024 | 11 | 0.240 |
Why?
|
| Cholesterol | 1 | 2025 | 63 | 0.240 |
Why?
|
| Air Pollution | 1 | 2024 | 16 | 0.240 |
Why?
|
| Environmental Exposure | 1 | 2024 | 17 | 0.240 |
Why?
|
| Particulate Matter | 1 | 2024 | 20 | 0.230 |
Why?
|
| Survivors | 3 | 2022 | 72 | 0.230 |
Why?
|
| Heterozygote | 1 | 2025 | 103 | 0.230 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 328 | 0.230 |
Why?
|
| Florida | 1 | 2023 | 22 | 0.220 |
Why?
|
| Sex Factors | 2 | 2022 | 480 | 0.210 |
Why?
|
| Tocopherols | 1 | 2023 | 9 | 0.210 |
Why?
|
| Risk Assessment | 2 | 2024 | 676 | 0.210 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 13 | 0.210 |
Why?
|
| Adult | 11 | 2023 | 8152 | 0.210 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 8 | 0.210 |
Why?
|
| Flavonols | 1 | 2022 | 11 | 0.210 |
Why?
|
| Regression Analysis | 4 | 2011 | 267 | 0.200 |
Why?
|
| Vitamins | 1 | 2022 | 21 | 0.200 |
Why?
|
| Brain Infarction | 1 | 2023 | 75 | 0.200 |
Why?
|
| Dietary Supplements | 1 | 2022 | 67 | 0.200 |
Why?
|
| Life Expectancy | 1 | 2022 | 28 | 0.200 |
Why?
|
| Age Factors | 2 | 2022 | 793 | 0.200 |
Why?
|
| Cognitive Reserve | 1 | 2022 | 39 | 0.190 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 5 | 0.190 |
Why?
|
| Stress, Psychological | 2 | 2014 | 243 | 0.190 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 39 | 0.180 |
Why?
|
| Cost of Illness | 1 | 2021 | 53 | 0.180 |
Why?
|
| Brain | 4 | 2024 | 1699 | 0.180 |
Why?
|
| Noise | 1 | 2020 | 31 | 0.180 |
Why?
|
| Early Diagnosis | 1 | 2020 | 68 | 0.180 |
Why?
|
| Mental Status Schedule | 2 | 2018 | 98 | 0.170 |
Why?
|
| Neuroimaging | 1 | 2020 | 133 | 0.170 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 164 | 0.160 |
Why?
|
| Confidence Intervals | 2 | 2017 | 97 | 0.160 |
Why?
|
| Residence Characteristics | 1 | 2020 | 216 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 12 | 0.160 |
Why?
|
| Phototherapy | 1 | 2019 | 36 | 0.160 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 227 | 0.160 |
Why?
|
| Social Networking | 1 | 2018 | 11 | 0.150 |
Why?
|
| Healthy Aging | 1 | 2018 | 14 | 0.150 |
Why?
|
| Hippocampus | 1 | 2020 | 281 | 0.150 |
Why?
|
| Interviews as Topic | 2 | 2016 | 136 | 0.150 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 28 | 0.150 |
Why?
|
| Behavioral Symptoms | 1 | 2018 | 15 | 0.150 |
Why?
|
| Odds Ratio | 2 | 2017 | 274 | 0.150 |
Why?
|
| Nursing Homes | 1 | 2018 | 37 | 0.150 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 311 | 0.150 |
Why?
|
| Social Environment | 1 | 2018 | 84 | 0.140 |
Why?
|
| Defecation | 1 | 2017 | 5 | 0.140 |
Why?
|
| Low Back Pain | 1 | 2019 | 121 | 0.140 |
Why?
|
| Starch | 1 | 2017 | 10 | 0.140 |
Why?
|
| Surveys and Questionnaires | 5 | 2016 | 1216 | 0.140 |
Why?
|
| Pain Management | 1 | 2019 | 147 | 0.140 |
Why?
|
| Microspheres | 1 | 2017 | 24 | 0.140 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 86 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2017 | 25 | 0.140 |
Why?
|
| Prebiotics | 1 | 2017 | 25 | 0.140 |
Why?
|
| Invasive Fungal Infections | 1 | 2017 | 5 | 0.140 |
Why?
|
| Mucormycosis | 1 | 2017 | 9 | 0.140 |
Why?
|
| Frozen Sections | 1 | 2017 | 13 | 0.140 |
Why?
|
| Aspergillosis | 1 | 2017 | 13 | 0.140 |
Why?
|
| Birth Order | 1 | 2016 | 1 | 0.140 |
Why?
|
| Parity | 1 | 2016 | 2 | 0.140 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 2 | 0.140 |
Why?
|
| Reproduction | 1 | 2016 | 10 | 0.140 |
Why?
|
| Iodide Peroxidase | 1 | 2018 | 112 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 46 | 0.140 |
Why?
|
| Warfare | 1 | 2016 | 14 | 0.130 |
Why?
|
| Inflammation | 1 | 2018 | 288 | 0.130 |
Why?
|
| Terrorism | 1 | 2016 | 14 | 0.130 |
Why?
|
| Interview, Psychological | 2 | 2014 | 42 | 0.130 |
Why?
|
| Parkinson Disease | 2 | 2022 | 847 | 0.130 |
Why?
|
| Reading | 1 | 2016 | 41 | 0.130 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 7 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2015 | 247 | 0.120 |
Why?
|
| Overweight | 2 | 2014 | 77 | 0.120 |
Why?
|
| Self Report | 1 | 2016 | 226 | 0.120 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 4 | 0.120 |
Why?
|
| Carbohydrates | 1 | 2015 | 6 | 0.120 |
Why?
|
| Insulin | 2 | 2014 | 90 | 0.120 |
Why?
|
| Chromatography, Gas | 1 | 2015 | 10 | 0.120 |
Why?
|
| Urinalysis | 1 | 2015 | 9 | 0.120 |
Why?
|
| Models, Genetic | 1 | 2015 | 35 | 0.120 |
Why?
|
| Blood Glucose | 2 | 2014 | 109 | 0.120 |
Why?
|
| Health Status | 2 | 2014 | 228 | 0.120 |
Why?
|
| Adipose Tissue | 3 | 2005 | 79 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 171 | 0.120 |
Why?
|
| Rhinitis | 1 | 2017 | 143 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2015 | 60 | 0.120 |
Why?
|
| Sinusitis | 1 | 2017 | 162 | 0.120 |
Why?
|
| Demography | 1 | 2014 | 75 | 0.120 |
Why?
|
| Hospitalization | 2 | 2014 | 322 | 0.110 |
Why?
|
| Intelligence Tests | 1 | 2014 | 15 | 0.110 |
Why?
|
| Cats | 1 | 2014 | 29 | 0.110 |
Why?
|
| Hypoglycemia | 1 | 2014 | 13 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2014 | 78 | 0.110 |
Why?
|
| Medicare | 1 | 2014 | 121 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 64 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 352 | 0.110 |
Why?
|
| Mindfulness | 1 | 2014 | 48 | 0.110 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 232 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 192 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2015 | 241 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 329 | 0.100 |
Why?
|
| Emergency Medicine | 1 | 2015 | 97 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 358 | 0.100 |
Why?
|
| Urban Population | 1 | 2013 | 159 | 0.100 |
Why?
|
| Colonoscopy | 1 | 2013 | 74 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 137 | 0.100 |
Why?
|
| Adenoma | 1 | 2013 | 61 | 0.100 |
Why?
|
| Social Support | 1 | 2014 | 216 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 51 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2011 | 44 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 113 | 0.090 |
Why?
|
| ROC Curve | 1 | 2011 | 145 | 0.090 |
Why?
|
| Gait | 1 | 2015 | 411 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 413 | 0.090 |
Why?
|
| Elder Abuse | 1 | 2011 | 36 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 104 | 0.090 |
Why?
|
| Frail Elderly | 1 | 2010 | 53 | 0.090 |
Why?
|
| Testosterone | 3 | 2004 | 28 | 0.080 |
Why?
|
| Self Care | 1 | 2010 | 105 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2010 | 204 | 0.080 |
Why?
|
| Quality of Life | 1 | 2014 | 660 | 0.080 |
Why?
|
| Femoracetabular Impingement | 1 | 2015 | 373 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 520 | 0.070 |
Why?
|
| Algorithms | 1 | 2010 | 378 | 0.070 |
Why?
|
| Common Cold | 1 | 2006 | 6 | 0.070 |
Why?
|
| Young Adult | 3 | 2018 | 2100 | 0.070 |
Why?
|
| C-Reactive Protein | 2 | 2018 | 104 | 0.060 |
Why?
|
| Animals | 1 | 2014 | 3798 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2019 | 440 | 0.060 |
Why?
|
| Smoking Prevention | 1 | 2005 | 17 | 0.060 |
Why?
|
| Phenotype | 2 | 2016 | 308 | 0.060 |
Why?
|
| Feces | 2 | 2017 | 109 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2005 | 40 | 0.060 |
Why?
|
| Observer Variation | 2 | 2015 | 104 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.060 |
Why?
|
| Peptide Hormones | 1 | 2004 | 3 | 0.060 |
Why?
|
| Copper | 1 | 2024 | 18 | 0.060 |
Why?
|
| Diet, Reducing | 1 | 2004 | 12 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2005 | 48 | 0.060 |
Why?
|
| Zinc | 1 | 2024 | 44 | 0.060 |
Why?
|
| Sulfotransferases | 1 | 2004 | 6 | 0.060 |
Why?
|
| Androgens | 1 | 2004 | 8 | 0.060 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 4 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2005 | 105 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2017 | 424 | 0.060 |
Why?
|
| Metabolic Syndrome | 1 | 2005 | 62 | 0.060 |
Why?
|
| Estrogens | 1 | 2004 | 26 | 0.060 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 213 | 0.060 |
Why?
|
| Parents | 1 | 2005 | 126 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 8 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 13 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 12 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 58 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 939 | 0.050 |
Why?
|
| Leisure Activities | 1 | 2022 | 15 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 103 | 0.050 |
Why?
|
| Diet Surveys | 1 | 2021 | 26 | 0.050 |
Why?
|
| Logistic Models | 2 | 2013 | 397 | 0.050 |
Why?
|
| Washington | 3 | 2006 | 5 | 0.050 |
Why?
|
| Atrophy | 1 | 2021 | 91 | 0.050 |
Why?
|
| Tremor | 1 | 2022 | 117 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 346 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 81 | 0.040 |
Why?
|
| Smoking | 2 | 2015 | 179 | 0.040 |
Why?
|
| Memory | 2 | 2011 | 308 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2019 | 21 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 8 | 0.040 |
Why?
|
| Child | 2 | 2018 | 1423 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 40 | 0.040 |
Why?
|
| Neurotic Disorders | 1 | 2018 | 19 | 0.040 |
Why?
|
| Threonine | 1 | 2018 | 10 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 24 | 0.040 |
Why?
|
| Alanine | 1 | 2018 | 13 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2018 | 60 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2018 | 22 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2018 | 68 | 0.040 |
Why?
|
| Awareness | 1 | 2018 | 45 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 109 | 0.040 |
Why?
|
| Chronic Pain | 1 | 2019 | 114 | 0.040 |
Why?
|
| Veterans | 1 | 2019 | 93 | 0.040 |
Why?
|
| Fermentation | 1 | 2017 | 12 | 0.040 |
Why?
|
| Constipation | 1 | 2017 | 19 | 0.040 |
Why?
|
| Liver | 1 | 2018 | 160 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2017 | 36 | 0.040 |
Why?
|
| Educational Status | 1 | 2018 | 298 | 0.030 |
Why?
|
| Mucor | 1 | 2017 | 5 | 0.030 |
Why?
|
| Aspergillus | 1 | 2017 | 7 | 0.030 |
Why?
|
| Nasal Surgical Procedures | 1 | 2017 | 10 | 0.030 |
Why?
|
| Adolescent | 2 | 2018 | 2324 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 15 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 11 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 45 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 53 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 18 | 0.030 |
Why?
|
| Russia | 1 | 2016 | 4 | 0.030 |
Why?
|
| Jews | 1 | 2016 | 4 | 0.030 |
Why?
|
| Israel | 1 | 2016 | 17 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 2016 | 16 | 0.030 |
Why?
|
| Nose | 1 | 2017 | 36 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 9 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 44 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 600 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 208 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 355 | 0.030 |
Why?
|
| Ankle | 1 | 2015 | 24 | 0.030 |
Why?
|
| Gallbladder | 1 | 2015 | 4 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 5 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 340 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 297 | 0.030 |
Why?
|
| Endoscopy | 1 | 2017 | 182 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 7 | 0.030 |
Why?
|
| Knee | 1 | 2015 | 46 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 22 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 42 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 44 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 184 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2015 | 37 | 0.030 |
Why?
|
| Decision Making | 1 | 2017 | 227 | 0.030 |
Why?
|
| Hip | 1 | 2015 | 65 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 119 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 185 | 0.030 |
Why?
|
| China | 1 | 2014 | 52 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2014 | 3612 | 0.030 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2014 | 8 | 0.030 |
Why?
|
| Body Weight | 2 | 2004 | 145 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 25 | 0.030 |
Why?
|
| Estrone | 2 | 2004 | 8 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2004 | 16 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 62 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2014 | 40 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 120 | 0.030 |
Why?
|
| Estradiol | 2 | 2004 | 41 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 177 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 46 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 651 | 0.030 |
Why?
|
| Patient Compliance | 2 | 2005 | 165 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 146 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 676 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 138 | 0.030 |
Why?
|
| Critical Illness | 1 | 2014 | 134 | 0.020 |
Why?
|
| Medical Record Linkage | 1 | 2011 | 1 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 105 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 725 | 0.020 |
Why?
|
| Length of Stay | 1 | 2014 | 328 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 76 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2014 | 295 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 208 | 0.020 |
Why?
|
| Cross Infection | 1 | 2014 | 282 | 0.020 |
Why?
|
| Trail Making Test | 1 | 2010 | 4 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2010 | 10 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2010 | 16 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 242 | 0.020 |
Why?
|
| Caregivers | 1 | 2011 | 203 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 2006 | 11 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 992 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 27 | 0.020 |
Why?
|
| Leptin | 1 | 2005 | 22 | 0.020 |
Why?
|
| Health Education | 1 | 2005 | 54 | 0.020 |
Why?
|
| Ghrelin | 1 | 2004 | 2 | 0.020 |
Why?
|
| Body Size | 1 | 2004 | 13 | 0.010 |
Why?
|
| Homeostasis | 1 | 2005 | 69 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2005 | 52 | 0.010 |
Why?
|
| Arylsulfotransferase | 1 | 2004 | 1 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 17 | 0.010 |
Why?
|
| Body Composition | 1 | 2005 | 69 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 25 | 0.010 |
Why?
|
| Energy Intake | 1 | 2004 | 83 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 59 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 61 | 0.010 |
Why?
|
| New Mexico | 1 | 2003 | 3 | 0.010 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2003 | 5 | 0.010 |
Why?
|
| Anthropometry | 1 | 2003 | 36 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 82 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 372 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 772 | 0.010 |
Why?
|